Condition (MeSH)
Hantavirus Infections
ClinicalTrials.gov lists 23 trials for Hantavirus Infections or a narrower condition beneath it. U.S. Army Medical Research and Development Command has the most among industry and government lead sponsors, with 6.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
6 of the 23 trials are tagged with Hantavirus Infections itself; the rest are tagged with a narrower condition beneath it.
When did Hantavirus Infections trials start? (14)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 1
- Phase 2
- Phase 4
- Not applicable
- Observational
Top of scale: 3
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2026 (partial year) | 3 |
| 2025 | 2 |
| 2022 | 3 |
| 2021 | 1 |
| 2020 | 3 |
| 2019 | 2 |
| 2015 | 1 |
| 2014 | 1 |
| 2013 | 1 |
| 2012 | 1 |
Showing 10 of 14 earlier years.
No forecast is made for this condition: it averages 1.6 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: none of the 23 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Hantavirus Infections trials in? (5)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 1 | 3 |
| Phase 2 | 5 |
| Phase 4 | 1 |
| Not applicable | 2 |
| Observational | 12 |
How many Hantavirus Infections trials are recruiting? (7)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Not yet recruiting | 2 |
| Recruiting | 4 |
| Active, not recruiting | 1 |
| Completed | 10 |
| Terminated | 1 |
Showing 5 of 7 statuses.
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Hantavirus Infections trials? (4)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| U.S. Army Medical Research and Development Command | 6 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 2 |
| Medtronic | 1 |
| OpenGenome | 1 |
Which drugs are being tested for Hantavirus Infections? (1)
Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.
| Drug | Trials |
|---|---|
| METHYLPREDNISOLONE | 1 |
Interventions as named in the registry (8)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| Ribavirine | 3 |
| Hantaan DNA Vaccine/Puumala DNA Vaccine | 1 |
| IVIG 10g/d | 1 |
| IVIG 20g/d | 1 |
| HTNV/PUUV DNA vaccine | 1 |
Showing 5 of 8 interventions.
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which serious adverse events do Hantavirus Infections trials report? (10)
Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.
| Adverse event | Subjects affected | Trials |
|---|---|---|
| Cardiac disorder | 26 | 1 |
| Hepatobiliary disorders | 26 | 1 |
| Respiratory, thoracic and mediastinal disorders | 7 | 1 |
| Renal and urinary disorders | 4 | 1 |
| Metabolism and nutrition disorders | 3 | 1 |
Showing 5 of 10 adverse events.
Which publications cover Hantavirus Infections? (4)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Molecular Detection of <i>Orthohantavirus puumalaense</i> in Plasma and Urine Samples from Hospitalized Patients Presenting with a Serologically Confirmed Acute Hantavirus Infection in France. | Journal of clinical microbiology | 2023 | Yes |
| Impact of the Yosemite hantavirus outbreak on hantavirus antibody testing at a national reference laboratory. | Clinical and vaccine immunology : CVI | 2013 | Yes |
| Puumala hantavirus genome in patients with nephropathia epidemica: correlation of PCR positivity with HLA haplotype and link to viral sequences in local rodents. | Journal of clinical microbiology | 1997 | Yes |
| Indirect immunofluorescence assay for the simultaneous detection of antibodies against clinically important old and new world hantaviruses. | PLoS neglected tropical diseases | 2013 | No |
Sub-conditions in MeSH (2)
MeSH descendants one level down with at least one trial, most trials first.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: prevalence and rare-disease identity.